Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
38292
CAS Number:
70024-40-7
Clorhidrato de terazosina dihidrato
Purity:
≥ 98 % (HPLC)
Synonym(s):
Clorhidrato de 4-amino-6,7-dimetoxi-2-[4-(tetrahidro-2-furoil)-1-piperazinil]quinazolina dihidrato
Documents
$20.63 /100 mg
Tamaño
Request Bulk Quote
Información del producto

Terazosin hydrochloride dihydrate is a potent alpha-1 adrenergic antagonist primarily utilized in the treatment of hypertension and benign prostatic hyperplasia (BPH). This compound works by relaxing blood vessels and improving urine flow, making it a valuable option for patients experiencing urinary difficulties associated with prostate enlargement. Its unique structure, featuring a piperazine ring and a quinazoline moiety, enhances its efficacy and selectivity, providing a favorable safety profile compared to other antihypertensive agents.

In addition to its therapeutic applications, Terazosin hydrochloride dihydrate is also of interest in research settings, particularly in studies related to cardiovascular health and urology. Its ability to modulate smooth muscle tone has led to investigations into its potential benefits in various conditions, including heart failure and peripheral vascular disease. Researchers and healthcare professionals appreciate its versatility and effectiveness, making it a reliable choice in both clinical and experimental environments.

Número CAS
70024-40-7
Fórmula molecular
C 19 H 25 N 5 O 4 ·HCl·2H 2 O
Peso molecular
459.93
Número MDL
MFCD00941408
Punto de fusión
273 - 275 °C
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
70024-40-7
Fórmula molecular
C 19 H 25 N 5 O 4 ·HCl·2H 2 O
Peso molecular
459.93
Número MDL
MFCD00941408
Punto de fusión
273 - 275 °C
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Terazosin hydrochloride dihydrate is widely utilized in research focused on

  • Hypertension Management: This compound is primarily used in the treatment of high blood pressure, helping to relax blood vessels and improve blood flow, making it a vital medication in cardiology.
  • BPH Treatment: It is effective in alleviating symptoms of benign prostatic hyperplasia (BPH), providing relief from urinary difficulties in men, which is crucial for urologists and primary care providers.
  • Research in Pharmacology: Terazosin serves as a model compound in pharmacological studies, allowing researchers to explore alpha-1 adrenergic receptor antagonism, which is essential for developing new medications.
  • Veterinary Medicine: The compound is also investigated for potential applications in veterinary medicine, particularly for treating conditions related to hypertension in animals.
  • Combination Therapies: Its use in combination with other antihypertensive agents is being explored, offering enhanced therapeutic effects and improved patient outcomes in clinical settings.

Citas